What is the first-line antibiotic treatment for uncomplicated leg cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotic Treatment for Uncomplicated Leg Cellulitis

For uncomplicated leg cellulitis, a cephalosporin (such as cephalexin), penicillin, or clindamycin is recommended as first-line therapy for 5 days, targeting primarily streptococci and methicillin-sensitive Staphylococcus aureus. 1

First-Line Antibiotic Options

  • Cephalexin 500 mg orally four times daily for 5 days 1
  • Penicillin or amoxicillin for streptococcal coverage 1, 2
  • Dicloxacillin for staphylococcal coverage 1
  • Clindamycin 300-450 mg orally four times daily for 5 days (especially for penicillin-allergic patients) 1, 3

Treatment Duration

  • A 5-day course of antibiotics is as effective as a 10-day course for uncomplicated cellulitis if clinical improvement occurs within the first 5 days 1, 4
  • Consider extending treatment if the infection has not improved after 5 days 1
  • The 2019 NICE guideline recommends a course of 5-7 days 1

MRSA Considerations

  • MRSA is an unusual cause of typical cellulitis 1
  • Standard beta-lactam therapy (like cephalexin) is successful in 96% of typical cellulitis cases 1
  • Consider MRSA coverage only in specific situations:
    • Cellulitis associated with penetrating trauma 1
    • Evidence of MRSA infection elsewhere 1, 3
    • Nasal colonization with MRSA 1
    • Injection drug use 1
    • Systemic inflammatory response syndrome 1
    • Purulent drainage 1, 3

MRSA Coverage Options (when indicated)

  • Oral options: Trimethoprim-sulfamethoxazole, doxycycline, or clindamycin 1, 3
  • If both streptococcal and MRSA coverage needed: Clindamycin alone or combination of trimethoprim-sulfamethoxazole or doxycycline with a beta-lactam 1
  • Intravenous options for severe infections: Vancomycin, daptomycin, linezolid, or telavancin 1, 3

Adjunctive Measures

  • Elevation of the affected area to promote drainage of edema and inflammatory substances 1, 3
  • Treatment of underlying conditions that may predispose to infection:
    • Tinea pedis 1, 3
    • Venous eczema/stasis dermatitis 1, 3
    • Lymphedema 1, 5

Prevention of Recurrence

  • Keep skin well hydrated with emollients 1
  • Reduce underlying edema through elevation, compression stockings, or diuretic therapy if appropriate 1
  • For frequent infections despite preventive measures, prophylactic antibiotics may be considered:
    • Monthly intramuscular benzathine penicillin injections of 1.2 MU 1
    • Oral therapy with twice-daily doses of either 250 mg of erythromycin or 1 g of penicillin V 1, 3

Clinical Pearls and Pitfalls

  • Cellulitis is primarily a clinical diagnosis - cultures of blood, tissue aspirates, or skin biopsies are unnecessary for typical cases 1, 6
  • Blood cultures should be obtained for patients with malignancy, severe systemic features, or unusual predisposing factors 1
  • Inflammation may worsen after initiating therapy due to pathogen destruction releasing enzymes that increase local inflammation 1
  • Distinguish cellulitis (which requires antibiotics) from purulent collections (which primarily require drainage) 1, 2
  • A recent trial showed no significant benefit of adding trimethoprim-sulfamethoxazole to cephalexin for uncomplicated cellulitis 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Recommendations for Cellulitis in Patients with Keflex Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cellulitis.

Infectious disease clinics of North America, 2021

Research

Cellulitis: A Review.

JAMA, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.